Advanced Enzyme Technologies Limited (ADVENZYMES.NS) NSE

Currency In INR

AD

Valuation

Market Cap28.56B
Enterprise Value27.72B
P/E Ratio20.24
PEG Ratio0.96
Price/Sales Ratio4.48
Price/Book Ratio2
Enterprise/Revenue4.48
Enterprise/EBITDA12.87

Fiscal Year

Fiscal YearMarch 31, 2026
Most Recent QuarterJune 30, 2026

Profitability

Profit Margin0.22
Operating Margin0.24
AD

Management Effectiveness

Return On Assets0
Return On Equity0.1

Income Statement

Revenue7.46B
Revenue/Share66.95
Gross Profit3.5B
EBITDA2.75B
Net Income1.69B
Diluted EPS15.06

Balance Sheet

Total Cash7.05B
Total Cash/Share0
Total Debt0
Total Debt/Equity0
Current Ratio0
Book Value Per Share150.31

Price History

52-Week Change-2.06
52-Week High419
52-Week Low251.95
Moving Average 50 Days325.68
Moving Average 200 Days315.34

Statistics

Average Volume328,313
Shares Outstanding111.98M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1.35
Trailing Annual Dividend Yield0.45
Payout Ratio0.35
Last Split Factor5:1
Last Split DateMay 25, 2017
AD